Enhertu is currently approved in more than 75 countries. (Reporting by Raechel Thankam Job; Editing by Shilpi Majumdar) FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield ...

The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a breast cancer treatment for patients who received endocrine therapy but are not suitable for ...